Macrophage Migration Inhibitory Factor (MIF) Upregulates CXCR7 and Contributes to Chemotherapy Resistance in Colorectal Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Macrophage Migration Inhibitory Factor (MIF) Upregulates CXCR7 and Contributes to Chemotherapy Resistance in Colorectal Cancer

Published:2024-07-17 Issue: Volume: Page:
ISSN:1085-9195
Container-title:Cell Biochemistry and Biophysics
language:en
Short-container-title:Cell Biochem Biophys

Author:

Hu Song,Feng Jiangyi,Fu Weijie,Guo Yi

Funder

Chongqing Municipal Science and Technology Bureau

Basic Research and Frontier Exploration Fund of the Science and Technology Commission of Yuzhong District of Chongqing

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12013-024-01430-6.pdf

Reference42 articles.

1. Biller, L. H., & Schrag, D. (2021). Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA, 325(7), 669–685

2. Siegel, R. L., et al. (2023). Colorectal cancer statistics, 2023. CA A Cancer Journal For Clinicians, 73(3), 233–254

3. Lewandowska, A., et al. (2022). Risk factors for the diagnosis of colorectal cancer. Cancer Control, 29, 10732748211056692

4. Xi, Y., & Xu, P. (2021). Global colorectal cancer burden in 2020 and projections to 2040. Translational Oncology, 14(10), 101174

5. Schmitt, M., & Greten, F. R. (2021). The inflammatory pathogenesis of colorectal cancer. Nature Reviews Immunology, 21(10), 653–667

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3